The efficacy of PSMA-PET/CT guiding MDT was evaluated in a cohort of 42 patients with early oligometastatic castrate-resistant PCa who received radiation to all metastatic sites to delay systemic therapy initiation. Here, FOLH1 is linked to posterior cortical atrophy.